v3.26.1
PROPERTY, PLANT AND EQUIPMENT
 12 Months Ended
Mar. 28, 2026
Property, Plant, and Equipment [Abstract]  
PROPERTY, PLANT AND EQUIPMENT PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment consisted of the following:
March 28, 2026March 29, 2025
(Dollars in Thousands)
Land$2,251 $1,985 
Building and building improvements109,793 105,079 
Plant equipment and machinery197,552 181,825 
Office equipment and information technology131,085 130,924 
Haemonetics equipment371,205 395,152 
Construction in progress29,943 22,229 
Property, plant and equipment, at cost841,829 837,194 
Less: accumulated depreciation(536,068)(553,142)
Property, plant and equipment, net$305,761 $284,052 
Depreciation expense was $61.2 million, $60.0 million and $55.8 million in fiscal 2026, 2025 and 2024, respectively.
In the fourth quarter of fiscal 2025, the Company completed the divestiture of its Whole Blood product line within its Blood Center business unit and all related assets and liabilities were sold. The property, plant and equipment related to the divestiture had a gross value of $40.8 million and a net carrying value of $7.8 million and has been removed from the consolidated balance sheets.
In the first quarter of fiscal 2025, the Company received $19.9 million of cash upon the sale of a manufacturing facility and related assets that previously met held for sale criteria, which resulted in a gain of $14.1 million that was recorded in selling, general and administrative expenses on the consolidated statements of income.